Alpha 2.0
Login Register
» Articles » PMID: 16801597

Lipoprotein(a) As a Predictor of Cardiovascular Disease in a Prospectively Followed Cohort of Patients with Type 1 Diabetes

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2006 Jun 28
PMID 16801597
Citations 9
Authors
Barbara Kollerits
Martin Auinger
Veronika Reisig
Thomas Kastenbauer
Arno Lingenhel
Karl Irsigler
Rudolf Prager
Florian Kronenberg
Affiliations
Soon will be listed here.
Citing Articles

Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes Mellitus.

Kostner K, Kostner G Int J Mol Sci. 2022; 23(7).

PMID: 35408941 PMC: 8998850. DOI: 10.3390/ijms23073584.

Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule.

Jawi M, Frohlich J, Chan S J Lipids. 2020; 2020:3491764.

PMID: 32099678 PMC: 7016456. DOI: 10.1155/2020/3491764.

Cardiovascular risk assessment and screening in diabetes.

Zhao Y Cardiovasc Endocrinol. 2019; 6(1):17-22.

PMID: 31646114 PMC: 6768525. DOI: 10.1097/XCE.0000000000000115.

Cardiovascular Risk in Type 1 Diabetes Mellitus.

Schofield J, Ho J, Soran H Diabetes Ther. 2019; 10(3):773-789.

PMID: 31004282 PMC: 6531592. DOI: 10.1007/s13300-019-0612-8.

Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review.

Bjornstad P, Eckel R Curr Diab Rep. 2018; 18(12):127.

PMID: 30328521 PMC: 6428207. DOI: 10.1007/s11892-018-1101-6.